139 related articles for article (PubMed ID: 22751129)
1. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
Eißmann M; Melzer IM; Fernández SB; Michel G; Hrabě de Angelis M; Hoefler G; Finkenwirth P; Jauch A; Schoell B; Grez M; Schmidt M; Bartholomae CC; Newrzela S; Haetscher N; Rieger MA; Zachskorn C; Mittelbronn M; Zörnig M
Oncogene; 2013 May; 32(20):2586-91. PubMed ID: 22751129
[TBL] [Abstract][Full Text] [Related]
2. Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia.
Choi J; Hwang YK; Sung KW; Kim DH; Yoo KH; Jung HL; Koo HH
Leuk Res; 2006 Aug; 30(8):1019-25. PubMed ID: 16388850
[TBL] [Abstract][Full Text] [Related]
3. Anti-apoptotic genes Aven and E1B-19K enhance performance of BHK cells engineered to express recombinant factor VIII in batch and low perfusion cell culture.
Nivitchanyong T; Martinez A; Ishaque A; Murphy JE; Konstantinov K; Betenbaugh MJ; Thrift J
Biotechnol Bioeng; 2007 Nov; 98(4):825-41. PubMed ID: 17514750
[TBL] [Abstract][Full Text] [Related]
4. The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential.
Melzer IM; Fernández SB; Bösser S; Lohrig K; Lewandrowski U; Wolters D; Kehrloesser S; Brezniceanu ML; Theos AC; Irusta PM; Impens F; Gevaert K; Zörnig M
Cell Death Differ; 2012 Sep; 19(9):1435-45. PubMed ID: 22388353
[TBL] [Abstract][Full Text] [Related]
5. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
Zhang X; Huang H; Xu Z; Zhan R
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
[TBL] [Abstract][Full Text] [Related]
6. Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma.
Baranski Z; Booij TH; Cleton-Jansen AM; Price LS; van de Water B; Bovée JV; Hogendoorn PC; Danen EH
J Pathol; 2015 Jul; 236(3):348-59. PubMed ID: 25757065
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis-inhibitor Aven is downregulated in defective spermatogenesis and a novel estrogen target gene in mammalian testis.
Laurentino S; Gonçalves J; Cavaco JE; Oliveira PF; Alves MG; de Sousa M; Barros A; Socorro S
Fertil Steril; 2011 Sep; 96(3):745-50. PubMed ID: 21718987
[TBL] [Abstract][Full Text] [Related]
8. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1.
Chau BN; Cheng EH; Kerr DA; Hardwick JM
Mol Cell; 2000 Jul; 6(1):31-40. PubMed ID: 10949025
[TBL] [Abstract][Full Text] [Related]
9. Identification of dAven, a Drosophila melanogaster ortholog of the cell cycle regulator Aven.
Zou S; Chang J; LaFever L; Tang W; Johnson EL; Hu J; Wilk R; Krause HM; Drummond-Barbosa D; Irusta PM
Cell Cycle; 2011 Mar; 10(6):989-98. PubMed ID: 21368576
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the ATM-activator protein Aven by CRM1-dependent nuclear export.
Esmaili AM; Johnson EL; Thaivalappil SS; Kuhn HM; Kornbluth S; Irusta PM
Cell Cycle; 2010 Oct; 9(19):3913-20. PubMed ID: 20935510
[TBL] [Abstract][Full Text] [Related]
11. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.
Figueroa B; Chen S; Oyler GA; Hardwick JM; Betenbaugh MJ
Biotechnol Bioeng; 2004 Mar; 85(6):589-600. PubMed ID: 14966800
[TBL] [Abstract][Full Text] [Related]
12. [Expression of antiapoptotic gene aven in de novo acute myeloid leukemia patients and its clinical significance].
Geng SX; DU X; Weng JY; Zhong LY; Guo R; Lu ZS; Chen ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1424-8. PubMed ID: 20030919
[TBL] [Abstract][Full Text] [Related]
13. Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL.
Kutuk O; Temel SG; Tolunay S; Basaga H
Eur J Cancer; 2010 Sep; 46(13):2494-505. PubMed ID: 20619636
[TBL] [Abstract][Full Text] [Related]
14. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
15. Akt regulation of Aven contributes to the sensitivity of cancer cells to chemotherapeutic agents.
Han KY; Hwang JW; Bae GU; Kim SN; Kim YK
Mol Med Rep; 2015 May; 11(5):3866-71. PubMed ID: 25573060
[TBL] [Abstract][Full Text] [Related]
16. Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice.
Shields BJ; Alserihi R; Nasa C; Bogue C; Alexander WS; McCormack MP
Leukemia; 2015 Apr; 29(4):927-38. PubMed ID: 25283843
[TBL] [Abstract][Full Text] [Related]
17. MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia.
Correia NC; Fragoso R; Carvalho T; Enguita FJ; Barata JT
Sci Rep; 2016 Aug; 6():31894. PubMed ID: 27550837
[TBL] [Abstract][Full Text] [Related]
18. A novel long non-coding RNA T-ALL-R-LncR1 knockdown and Par-4 cooperate to induce cellular apoptosis in T-cell acute lymphoblastic leukemia cells.
Zhang L; Xu HG; Lu C
Leuk Lymphoma; 2014 Jun; 55(6):1373-82. PubMed ID: 23906015
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
[TBL] [Abstract][Full Text] [Related]
20. Survivin and aven: two distinct antiapoptotic signals in acute leukemias.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Sahin B; Burgut R
Ann Oncol; 2003 Jul; 14(7):1045-50. PubMed ID: 12853345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
